Andre works for the fund that drove us down to .67, they might well be the one that now have planted us at 1.65, to continue to accumulate. andre is a plant and have always been. Now when the fund is changing it's position so is andre. Now he says he bought some at .8-.9 out of nostalgia..................Hogwash.........
He estimated that EPI a/B rated would be wort around 10 cents (even went as far as 50 cents when giving a range) to the share value of ATRS and now he restates that he is here for the QST party.
Hell QST with an upfront payment and a 50/50 split with a large partner should be worth close to 15 to 75 cent using andres calculations................
We have to crack 1.65 that is now the Holy Grail for the manipulator(s) for some reason. On Tuesday there was about 1.1 million shares traded between 1.66 and 1.79 maybe that has something to do with it.............
And by the way those "couple of weeks" is now a month and not a peep more has been heard on that particular issue.......
From what I understand it has to be a separate entity i.e not "Mylan USA" also the thing will have to be sold with a new Product name.
This is a bit like when you said or she sai that they would have a generic of their own EPi in a couple of weeks.
Conveniently forgetting the fact that a company cannot itself sell a Generic of their own medicine. I has to be sold by a separate entity under a different name i.e they will have to set up a subsidiary or get a completely different company to sell the generic version of EPI.
Nothing is around the corner when it comes to new meds as investors in Antares are acutely aware of.
Judging by the end of day action I was not wrong after all, they sure tried to get it down to 1.65.
Good news is that it's still higher than their previous 1.60 so upward and onward.......
whogo/icantrade/daviscupper etal is that your red thumb?
I've noticed you have not posted in a whole week. Are you suffering from shorting at the wrong time numbness?
Sweet indeed, goodbye 1.60 onwards and upwards.....he added hopefully :o)
As we inch ever closer to the day that brand-spanking-new Chevrolet Bolts begin to roll off their assembly line, Chevy is working hard to keep us interested by drip-feeding us facts and figures about General Motors's new electric car. Last week, The Drive reported on the news that Chevy's Tesla Model 3 fighter will have a range of 238 miles; now, Chevrolet has revealed just how much the Bolt will cost when it goes on sale later this year.
Chevy announced Tuesday that the Bolt would officially start at $37,495, including the destination charge. That price should come as little surprise to enthusiastic EV-watchers; since the hatchback's official debut earlier this year, GM has been claiming the Bolt would be priced around $37,500.
chevrolet bolt price the drive
More importantly, that MSRP means that the federal government's $7,500 tax rebate for electric vehicle purchasers brings the Bolt's true starting price down to a mere $29,995. And on top of Uncle Sam's tax break, many states also offer their own fiscal credits for purchasing an electric car; thanks to Colorado's generous tax breaks, for example, a Bolt there could cost as little as $23,995.
Less than $30,000 for a fully-electric hatchback that can easily go more than 200 miles on a single charge doesn't sound like an awful deal to us. Especially when you consider that its main competitor—indeed, the only other electric car in that price bracket expected to have a similar driving range—is probably still at least a year from arriving in customer's driveways. Unless you're a fanatical member of the Tesla cult, we'd say it's at least worth taking a look in the Chevrolet showroom.